Viking Therapeutics Statistics
Total Valuation
VKTX has a market cap or net worth of $3.13 billion. The enterprise value is $2.28 billion.
Important Dates
The last earnings date was Wednesday, April 23, 2025, after market close.
Earnings Date | Apr 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
VKTX has 112.31 million shares outstanding. The number of shares has increased by 10.50% in one year.
Current Share Class | 112.31M |
Shares Outstanding | 112.31M |
Shares Change (YoY) | +10.50% |
Shares Change (QoQ) | +0.65% |
Owned by Insiders (%) | 2.12% |
Owned by Institutions (%) | 73.50% |
Float | 109.88M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.69 |
P/TBV Ratio | 3.69 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 44.25, with a Debt / Equity ratio of 0.00.
Current Ratio | 44.25 |
Quick Ratio | 43.52 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1,914.63 |
Financial Efficiency
Return on equity (ROE) is -14.40% and return on invested capital (ROIC) is -12.08%.
Return on Equity (ROE) | -14.40% |
Return on Assets (ROA) | -11.74% |
Return on Invested Capital (ROIC) | -12.08% |
Return on Capital Employed (ROCE) | -20.33% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.56M |
Employee Count | 36 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.96% in the last 52 weeks. The beta is 0.75, so VKTX's price volatility has been lower than the market average.
Beta (5Y) | 0.75 |
52-Week Price Change | -64.96% |
50-Day Moving Average | 26.51 |
200-Day Moving Average | 45.74 |
Relative Strength Index (RSI) | 55.49 |
Average Volume (20 Days) | 4,227,652 |
Short Selling Information
The latest short interest is 25.46 million, so 22.67% of the outstanding shares have been sold short.
Short Interest | 25.46M |
Short Previous Month | 25.62M |
Short % of Shares Out | 22.67% |
Short % of Float | 23.17% |
Short Ratio (days to cover) | 6.02 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -172.32M |
Pretax Income | n/a |
Net Income | -128.24M |
EBITDA | n/a |
EBIT | -172.32M |
Earnings Per Share (EPS) | -$1.15 |
Full Income Statement Balance Sheet
The company has $851.86 million in cash and $1.00 million in debt, giving a net cash position of $850.86 million or $7.58 per share.
Cash & Cash Equivalents | 851.86M |
Total Debt | 1.00M |
Net Cash | 850.86M |
Net Cash Per Share | $7.58 |
Equity (Book Value) | 846.92M |
Book Value Per Share | 7.54 |
Working Capital | 846.45M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -133.99M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |